Enterprise Bank & Trust CO Abbott Laboratories Transaction History

Enterprise Bank & Trust CO

$291 Million
Q2 2024

A detailed history of Enterprise Bank & Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Enterprise Bank & Trust CO holds 28,425 shares of ABT stock, worth $3.24 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

28,425

Previous 28,344 0.29%

Holding current value

$3.24 Million

Previous $3.22 Million 8.32%

% of portfolio

1.01%

Previous 1.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	BUY	$100.73 - $112.44 $8,159 - $9,107	81 Added 0.29%	28,425 $2.95 Million
Q1 2024 Apr 10, 2024	SELL	$109.52 - $120.96 $75,459 - $83,341	-689 Reduced 2.37%	28,344 $3.22 Million
Q4 2023 Jan 09, 2024	BUY	$90.19 - $110.4 $202,115 - $247,406	2,241 Added 8.36%	29,033 $3.2 Million
Q3 2023 Oct 16, 2023	SELL	$95.53 - $114.62 $1,146 - $1,375	-12 Reduced 0.04%	26,792 $2.59 Million
Q2 2023 Jul 06, 2023	BUY	$100.78 - $112.29 $64,297 - $71,641	638 Added 2.44%	26,804 $2.92 Million
Q1 2023 Apr 11, 2023	BUY	$96.86 - $114.01 $17,725 - $20,863	183 Added 0.7%	26,166 $2.65 Million
Q4 2022 Jan 11, 2023	BUY	$95.06 - $111.52 $148,293 - $173,971	1,560 Added 6.39%	25,983 $0
Q3 2022 Oct 06, 2022	BUY	$96.76 - $112.03 $9,869 - $11,427	102 Added 0.42%	24,423 $2.36 Million
Q2 2022 Jul 06, 2022	SELL	$102.07 - $123.37 $201,894 - $244,025	-1,978 Reduced 7.52%	24,321 $2.64 Million
Q1 2022 Apr 13, 2022	SELL	$114.02 - $139.04 $195,886 - $238,870	-1,718 Reduced 6.13%	26,299 $3.11 Million
Q4 2021 Jan 03, 2022	BUY	$115.53 - $141.46 $24,607 - $30,130	213 Added 0.77%	28,017 $3.94 Million
Q3 2021 Oct 04, 2021	SELL	$116.66 - $129.06 $37,097 - $41,041	-318 Reduced 1.13%	27,804 $3.29 Million
Q2 2021 Jul 06, 2021	BUY	$105.79 - $124.53 $22,956 - $27,023	217 Added 0.78%	28,122 $3.26 Million
Q1 2021 Apr 15, 2021	BUY	$108.84 - $128.23 $20,788 - $24,491	191 Added 0.69%	27,905 $3.34 Million
Q4 2020 Jan 05, 2021	BUY	$105.0 - $114.42 $5,145 - $5,606	49 Added 0.18%	27,714 $3.03 Million
Q3 2020 Oct 16, 2020	SELL	$91.64 - $111.29 $181,813 - $220,799	-1,984 Reduced 6.69%	27,665 $3.01 Million
Q2 2020 Jul 10, 2020	BUY	$76.57 - $98.0 $56,125 - $71,834	733 Added 2.53%	29,649 $2.71 Million
Q1 2020 Apr 07, 2020	SELL	$62.82 - $91.86 $103,464 - $151,293	-1,647 Reduced 5.39%	28,916 $2.28 Million
Q4 2019 Jan 07, 2020	BUY	$78.51 - $87.4 $41,217 - $45,885	525 Added 1.75%	30,563 $2.66 Million
Q3 2019 Oct 07, 2019	BUY	$81.84 - $88.74 $81,758 - $88,651	999 Added 3.44%	30,038 $2.51 Million
Q2 2019 Jul 12, 2019	SELL	$72.88 - $85.0 $2,550 - $2,975	-35 Reduced 0.12%	29,039 $2.44 Million
Q1 2019 Apr 24, 2019	BUY	$66.22 - $80.06 $1.93 Million - $2.33 Million	29,074 New	29,074 $2.32 Million

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Bank & Trust CO with notifications on news.

Account

Enterprise Bank & Trust CO Abbott Laboratories Transaction History